Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy subjects.

被引：0
|
作者：
Liu, P [1 ]
Foster, G [1 ]
Labadie, R [1 ]
Gutierrez, MJ [1 ]
Sharma, A [1 ]
机构：
[1] Pfizer Inc, CNS Neurosci Inc, Groton, CT 06340 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P40 / P40
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects
    Liu, Ping
    Foster, Grover
    LaBadie, Robert R.
    Gutierrez, Maria J.
    Sharma, Amarnath
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (01): : 73 - 84
  • [2] ASSESSMENT OF PHARMACOKINETIC INTERACTION BETWEEN PRADIGASTAT AND EFAVIRENZ OR REPAGLINIDE IN HEALTHY SUBJECTS.
    Kulmatycki, K. M.
    Meyers, D.
    Danis, K.
    Neelakantham, S.
    Su, Z.
    Majumdar, T.
    Sam, R.
    Sunkara, G.
    Chen, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S48 - S49
  • [3] Lack of pharmacokinetic interaction between retigabine and phenobarbital at steady-state in healthy subjects.
    Ferron, GM
    Patat, A
    Parks, V
    Rolan, P
    Troy, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P48 - P48
  • [4] EVALUATION OF THE POTENTIAL FOR STEADY-STATE PHARMACOKINETIC INTERACTION BETWEEN ATORVASTATIN AND ASPIRIN IN HEALTHY SUBJECTS.
    Cho, H.
    Cho, D.
    Yeo, C.
    Bae, S.
    Shon, J.
    Park, S.
    Kim, E.
    Shin, J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S95 - S95
  • [5] No pharmacokinetic interaction between nebivolol and furosemide in healthy subjects.
    Morton, TL
    Liu, S
    Phillips, JL
    Donnelly, CM
    Rackley, RJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P79 - P79
  • [6] No pharmacokinetic interaction between saxagliptin and digoxin in healthy subjects.
    Boulton, D. W.
    Li, L.
    Patel, C. G.
    Komoroski, B. J.
    Whigan, D.
    Frevert, E. U.
    Kornhauser, D. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S93 - S93
  • [7] No pharmacokinetic interaction between trimethoprim and paliperidone ER in healthy subjects.
    Cleton, A
    Cleton, A
    Talluri, K
    Leempoels, J
    Thyssen, A
    Janssens, L
    Eerdekens, M
    Boom, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P22 - P22
  • [8] Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects.
    Wrishko, Rebecca E.
    Dingemanse, Jasper
    Yu, Albert
    Darstein, Christelle
    Phillips, Diane L.
    Mitchell, Malcolm I.
    [J]. CHEST, 2006, 130 (04) : 254S - 254S
  • [9] Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Sunkara, G
    Reynolds, CV
    Pommier, F
    Humbert, H
    Yeh, CM
    McLeod, J
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1067 - 1067
  • [10] Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects
    Liu, Ping
    Foster, Grover
    Gandelman, Kuan
    LaBadie, Robert R.
    Allison, Mark J.
    Gutierrez, Maria J.
    Sharma, Amarnath
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (10) : 3617 - 3626
12345